Vancouver, British Columbia--(Newsfile Corp. - February 26, 2016) - Harvard Apparatus Regenerative Technology (OTC: HART), President & CEO, Jim McGorry explains the company's focus on developing bio-engineered organs for lung & esophageal cancer and life threatening conditions of the trachea.
If you cannot view the video above, please visit:
http://www.b-tv.com/hart-ceo-clip/
HART is being featured on CBC's Documentary Channel Feb 22 - Mar 6, 2016, Monday through Friday, throughout the day and evenings.
About HART (OTC: HART)
HART's central focus continues to be the development of bioengineered organs for life-threatening conditions. They have built a dedicated internal team of materials scientists, engineers and biologists who are working with collaborators at major medical and research centers to bring their products to the patients who need them as quickly as possible. http://www.harvardapparatusregen.com/
About CEO Clips:
CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada. These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com. They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.
BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com
copyright (c) newsfile corp. 2016